Dendritic cell vaccines to combat glioblastoma. Apr 2010 - Expert Rev Neurother; 10(4):1744-8360 [PMID:20367199] [Wheeler CJ]
DCVax-Brain and DC vaccines in the treatment of GBM. Apr 2009 - Expert Opin Investig Drugs; 18(4):1744-7658 [PMID:19335279] [Wheeler CJ] [Black KL]
Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients. Jul 2008 - Cancer Res.; 68(14):1538-7445 [PMID:18632651] [Wheeler CJ] [Black KL] [Liu G] [Mazer M] [Zhang XX] [Pepkowitz S] [Goldfinger D] [Ng H] [Irvin D] [Yu JS]
Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination. Aug 2004 - Clin. Cancer Res.; 10(16):1078-0432 [PMID:15328167] [Wheeler CJ] [Das A] [Liu G] [Yu JS] [Black KL]
Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma. Jul 2004 - Cancer Res.; 64(14):0008-5472 [PMID:15256471] [Yu JS] [Liu G] [Ying H] [Yong WH] [Black KL] [Wheeler CJ]
Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. Feb 2001 - Cancer Res.; 61(3):0008-5472 [PMID:11221866] [Yu JS] [Wheeler CJ] [Zeltzer PM] [Ying H] [Finger DN] [Lee PK] [Yong WH] [Incardona F] [Thompson RC] [Riedinger MS] [Zhang W] [Prins RM] [Black KL]